Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2026-01-06 @ 10:25 PM
Study NCT ID:
NCT04613492
Status:
TERMINATED
Last Update Posted:
2025-06-24
First Post:
2020-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D7880C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None